HomeCompareFIRRY vs JNJ

FIRRY vs JNJ: Dividend Comparison 2026

FIRRY yields 5.05% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FIRRY wins by $6472.62M in total portfolio value
10 years
FIRRY
FIRRY
● Live price
5.05%
Share price
$9.50
Annual div
$0.48
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6472.65M
Annual income
$6,235,241,349.52
Full FIRRY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — FIRRY vs JNJ

📍 FIRRY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFIRRYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FIRRY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FIRRY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FIRRY
Annual income on $10K today (after 15% tax)
$428.86/yr
After 10yr DRIP, annual income (after tax)
$5,299,955,147.09/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, FIRRY beats the other by $5,299,951,161.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FIRRY + JNJ for your $10,000?

FIRRY: 50%JNJ: 50%
100% JNJ50/50100% FIRRY
Portfolio after 10yr
$3236.34M
Annual income
$3,117,623,019.46/yr
Blended yield
96.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FIRRY
No analyst data
Altman Z
1.9
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FIRRY buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFIRRYJNJ
Forward yield5.05%2.13%
Annual dividend / share$0.48$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$6472.65M$30.3K
Annual income after 10y$6,235,241,349.52$4,689.40
Total dividends collected$6456.01M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FIRRY vs JNJ ($10,000, DRIP)

YearFIRRY PortfolioFIRRY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,709$1,009.07$10,592$272.30+$1.1KFIRRY
2$14,737$2,208.47$11,289$357.73+$3.4KFIRRY
3$20,964$5,195.53$12,123$472.89+$8.8KFIRRY
4$36,247$13,814.72$13,141$629.86+$23.1KFIRRY
5$83,429$44,645.14$14,408$846.81+$69.0KFIRRY
6$281,344$192,074.92$16,021$1,151.60+$265.3KFIRRY
7$1,511,741$1,210,703.10$18,122$1,588.22+$1.49MFIRRY
8$13,777,290$12,159,726.68$20,930$2,228.20+$13.76MFIRRY
9$221,878,094$207,136,394.08$24,792$3,191.91+$221.85MFIRRY
10$6,472,650,910$6,235,241,349.52$30,274$4,689.40+$6472.62MFIRRY

FIRRY vs JNJ: Complete Analysis 2026

FIRRYStock

First Tractor Company Limited engages in the research and development, manufacture, and sale of agricultural and power machinery, and related spare parts worldwide. The company operates through three divisions: Agricultural Machinery, Power Machinery, and Finance. It offers wheeled and crawler tractors, and its components, such as castings, forgings gears, gear boxes, and covers; and off-road diesel engines, as well as accessory parts, including fuel injection pumps and fuel injectors. The company also engages in the fund settlement; provision of financial services; and processing and sale of rough and semi-finished, and finished products of castings and forging products. In addition, it provides loans, finance lease, bill acceptance and discounting, entrusting loans, and investments to member companies, as well as equity and portfolio investment in financial institutions as approved; and consumer credit service, buyer's credit, and finance lease for products of member companies and inter-bank borrowing and lending. The company was formerly known as First Tractor Works of China. First Tractor Company Limited was founded in 1955 and is based in Luoyang, China.

Full FIRRY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this FIRRY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FIRRY vs SCHDFIRRY vs JEPIFIRRY vs OFIRRY vs KOFIRRY vs MAINFIRRY vs ABBVFIRRY vs MRKFIRRY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.